Leqvio still a slow start on sales | ALNY Message Board Posts


Alnylam Pharmaceuticals

  ALNY website

ALNY   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  35086 of 35106  at  7/22/2022 12:33:31 PM  by

Steve_382


Leqvio still a slow start on sales

 From the Q2 NVS report. I did my part, getting my first shot a month ago. No real side effects and plan to get a lipid panel in a week or two to check efficacy.
 
Leqvio
(USD 22 million) launch in the US and other markets is ongoing, with focus on patient on-boarding, removing access hurdles and enhancing medical education
 


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 0  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
35096 Re: Leqvio still a slow start on sales Steve_382 2 8/3/2022 3:29:25 PM
35103 Re: Leqvio still a slow start on sales Steve_382 0 10/25/2022 5:59:37 PM




Financial Market Data provided by
.
Loading...